公司资料
Enveric Biosciences 股价、新闻与催化剂
- 股票代码:
- ENVB
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.41 USD (-1.40%)
收盘价
最后更新: 2026年8月24日
8.17M USD
市值
股价为何变动
As of Aug 24, 2026, ENVB closed down 1.40% at $1.41. No new same-company headline was identified in the current news window.
公司概览
业务概览
Enveric Biosciences is a neuroscience company focused on next-generation psychedelic-inspired and other CNS therapies. Its story centers on mental-health biology and the search for differentiated neuropsychiatric treatments.
所在地与行业分类
Enveric is headquartered in the United States and listed on NASDAQ. It sits in small-cap neuroscience biotechnology.
商业模式特征
The company depends on preclinical and early clinical work, translational validation, and capital support. Investors usually watch platform updates, strategic focus, and the ability to maintain a coherent CNS thesis.
生物医药行业定位
Enveric occupies a speculative neuroscience niche within biotech. It is a high-risk story where early platform proof matters a great deal.
未来催化剂
- Enveric’s catalysts are psycho-oncology and CNS-related programs, plus any update that shows the platform can still generate value. The market remains early-stage and data-sensitive.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。